Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort.

doi:10.1016/j.lungcan.2018.01.005

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohort.

Lung cancer (Amsterdam, Netherlands) - 1 Mar 2018

Okamoto Isamu, Morita Satoshi, Tashiro Naoki, Imamura Fumio, Inoue Akira, Seto Takashi, Yamamoto Nobuyuki, Ohe Yuichiro, Nakagawa Kazuhiko, Fukuoka Masahiro

Abstract excerpt

OBJECTIVES: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have been shown to be effective for the treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC) in clinical trials. However, there is a lack of data from routine clinical practice. This study determined treatment and outcomes in patients with EGFR mutation-positive NSCLC treated in a real world setting. MATERIALS...

Topics

Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Carcinoma, Non-Small-Cell Lung
Cohort Studies
ErbB Receptors
Female
Follow-Up Studies
Humans
Japan
Lung Neoplasms
Male

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Middle Aged

Mutation

Protein Kinase Inhibitors

Retrospective Studies

Survival Analysis

Source

Open in PubMed

Identifiers

PMID: 29496250
DOI: 10.1016/j.lungcan.2018.01.005

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.